M. E. Marongiu
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in ⓘ
- Virology 11
- HIV Research and Treatment 10
-
- HIV/AIDS drug development and treatment 12
- Co-authors
- P. La Colla (14 shared papers)Alessandra Pani (13 shared papers)Marino Artico (7 shared papers)Silvio Massa (7 shared papers)Antonello Mai (5 shared papers)Enzo Tramontano (5 shared papers)Fabio Marongiu (6 shared papers)Ezio Laconi (6 shared papers)
- Journals
- Cellular and Molecular Life Sciences (5 papers)Antiviral chemistry & chemotherapy (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Antiviral Research (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
M. E. Marongiu
35 papers receiving 441 citations
Peers
Comparison fields: 5 of 78
- Virology 95
- Infectious Diseases 152
- Hepatology 47
- Organic Chemistry 133
- Aging 7
Countries citing papers authored by M. E. Marongiu
This map shows the geographic impact of M. E. Marongiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Marongiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Marongiu more than expected).
Fields of papers citing papers by M. E. Marongiu
This network shows the impact of papers produced by M. E. Marongiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Marongiu. The network helps show where M. E. Marongiu may publish in the future.
Co-authors
The 25 scholars most cited alongside M. E. Marongiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 70 | |
| 2 | 1999 | 41 | |
| 3 | 1981 | 36 | |
| 4 | 2004 | 29 | |
| 5 | 1988 | 28 | |
| 6 | 2001 | 28 | |
| 7 | 2015 | 22 | |
| 8 | 1990 | 21 | |
| 9 | 1991 | 21 | |
| 10 | 2017 | 19 | |
| 11 | 2015 | 16 | |
| 12 | 2014 | 14 | |
| 13 | Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors. | 1994 | 12 |
| 14 | 2014 | 10 | |
| 15 | 2018 | 10 | |
| 16 | Approaches to antiviral drug development. | 1989 | 9 |
| 17 | 1979 | 9 | |
| 18 | 1993 | 8 | |
| 19 | 2021 | 6 | |
| 20 | 1991 | 6 |
About M. E. Marongiu
M. E. Marongiu is a scholar working on Virology, Infectious Diseases, Hepatology, Organic Chemistry and Management of Technology and Innovation, having authored 36 papers that have together received 453 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (10 papers), Liver physiology and pathology (5 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers), Organ Transplantation Techniques and Outcomes (5 papers), Synthesis and Biological Evaluation (3 papers), Synthesis and biological activity (3 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Virology (95 citations), Infectious Diseases (152 citations), Hepatology (47 citations), Organic Chemistry (133 citations) and Aging (7 citations). M. E. Marongiu has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include P. La Colla, Alessandra Pani, Marino Artico, Silvio Massa, Antonello Mai, Enzo Tramontano, Fabio Marongiu, Ezio Laconi, Paolo La Colla and Maria Paola Serra. Their work appears in journals such as Cellular and Molecular Life Sciences, Antiviral chemistry & chemotherapy, Bioorganic & Medicinal Chemistry Letters, Antiviral Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.